Journal of Pharmacy and Pharmaceutical Sciences

Papers
(The TQCC of Journal of Pharmacy and Pharmaceutical Sciences is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Ensuring guideline adherence and cost savings in stress ulcer prophylaxis practices in the intensive care unit: a pre-post education study75
Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines55
Should Codeine Still be Considered a WHO Essential Medicine?47
Development of a Rat Sandwich-Cultured Hepatocytes Model Expressing Functional Human Organic Anion Transporting Polypeptide (OATP) 1B3: A Potential Screening Tool for Liver-Targeting Compounds44
A Survey of the Criteria Used for the Selection of Alternative Comparator Products by Participating Regulators and Organizations of the International Pharmaceutical Regulators Programme41
Microneedles as an Alternative Strategy for Drug Delivery24
Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database23
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials21
Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease18
Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition16
Grading pharmacists’ risk of complaints to a regulator: A retrospective cohort study15
Weighing in on the role of brown adipose tissue for treatment of obesity14
What a pain in the … back: a review of current treatment options with a focus on naproxen sodium13
Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred13
Remdesivir-induced conduction abnormalities: A molecular model-based explanation12
The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking12
A new method for investigating bioequivalence of inhaled formulations: A pilot study on salbutamol11
The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study11
Evaluating the Effects of Agomelatine on Polysomnography Parameters in Patients with Obstructive Sleep Apnea.11
High-quality reports and their characteristics in the Japanese Adverse Drug Event Report database (JADER)11
Factors Influencing 1st and 2nd Generation Drug-Eluting Stent Performance: Understanding the Basic Pharmaceutical Drug-in-Polymer Formulation Factors Contributing to Stent Thrombosis Do We Really Need10
The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: diffe10
Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs9
Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System8
Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions8
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments8
A Review of Electronic Cigarettes and Liquid Nicotine Poisoning Exposure Cases in the United States7
Effectiveness and safety evaluation of thrice weekly double strength vs daily single strength trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia after kidney transplanta7
Integration of real-world evidence from different data sources in health technology assessment7
The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis7
A big leap in prescription drug promotion in Canada6
Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract6
Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective6
Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Difference6
Changes in Rosuvastatin Pharmacokinetics During Postnatal Ontogenesis in Rats6
0.10151505470276